Pirche announced its participation in the prestigious Texas Transplant Society 2024 Annual Scientific Meeting which took place last week in San Antonio, Texas.

BERLIN, BERLIN, GERMANY, July 29, 2024 /EINPresswire.com/ -- Pirche, a leading provider of AI to transplant medicine, announced its participation in the prestigious Texas Transplant Society 2024 Annual Scientific Meeting, which took place from July 26-28 at the Hilton Palacio Del Rio in San Antonio, Texas. This event served as a pivotal platform for experts in the field of organ transplantation to share knowledge, collaborate on advancements, and explore emerging technologies.

At the symposium, Pirche showcased its cutting-edge digital diagnostic platform TxPredictor, aimed at revolutionizing immune risk stratification through deep analysis of immune compatibility. With a commitment to improving patient outcomes and addressing critical challenges in the field, Pirche's presence proved its dedication to advancing the science and practice of transplantation medicine.

"We were thrilled to participate in the Texas Transplant Symposium 2024, where we highlighted our latest advancements in organ risk stratification technologies," said Thomas Klein, Founder and CEO of Pirche. "This event provided an invaluable opportunity to engage with leading clinicians, researchers, and industry peers to drive forward innovations that could potentially transform the landscape of organ transplantation."

Throughout the symposium, attendees visited Pirche's booth to learn more about the company's proprietary solutions designed to optimize immune system compatibility and attended a special presentation on Sunday, July 28th, 2024, by Dr. Udeme Ekong, MD, MPH, FAASLD, Associate Professor of Pediatrics and Surgery and Attending Physician at the Medstar Georgetown Transplant Institute. Dr. Ekong delivered a talk titled "Monitoring Immunosuppression in Liver Transplant Recipients - Unmet Needs and Advances in 2024." This session highlighted critical insights into recent developments in immunosuppression monitoring and tests to consider for monitoring allograft health.

For more information about Pirche and its participation in the Texas Transplant Symposium 2024, visit www.pirche.com.

Morgan Giannattasio
Pirche AG
+1 631-891-9374
morgan.giannattasio@pirche.com
Visit us on social media:
Facebook
LinkedIn
Instagram
YouTube